×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
The State of Clinical Outsourcing: Do Outsourcing Partnerships Promote or Impede Progress Toward Clinical Trial Optimization?
Session Chair(s)
Denise A. Calaprice-Whitty, PhD, MS
Consultant
The Avoca Group, United States
This forum will explore best practices for using outsourcing relationships to promote intelligent (data-driven) approaches in clinical trial design and management. Experts will provide perspectives on data from an industry survey, sharing thoughts on areas of opportunity.
Learning Objective : Identify opportunities for outsourcing relationships to promote novel and more intelligent approaches to optimizing clinical trial execution; Describe how outsourcing relationships may inhibit the ability for companies to adopt novel and more intelligent approaches to clinical trial execution and include tactics for overcoming these challenges.
Speaker(s)
Perspectives and Reflection on Data from Industry Survey
Rhonda Henry, BSN, RN
Evidera, United States
Vice President, Patient Centered Trials
Perspectives and Reflection on Data from Industry Survey
Elspeth Carnan, PhD
Amgen Inc., United States
Executive Director, Operational Efficiency
Perspectives and Reflection on Data from Industry Survey
Kathleen Ford, BSN, RN
Merck KGaA, Germany
Senior Vice President, Head of Global Clinical Operations
Have an account?